The Rising Prevalence of Infectious Diseases and Rising Number of Cases of Different Types of Cancer is Expected to Boost the Growth of the Global Molecular Diagnostics Market at a CAGR of 5.70% During the Forecast Period 2023 to 2032

Pune, India, 2023, MRFR Press Release/- Market Research Future (MRFR) has published a cooked research report on the “Global Molecular Diagnostics Market” that contains information from 2018 to 2032. 

Market Highlights

The global Molecular Diagnostics market is accounted to register a CAGR of 5.70% during the forecast period and is estimated to reach USD 30.46 Billion by 2032.

The Molecular Diagnostics Market refers to the field of medical diagnostics that uses molecular biology techniques to identify and analyze biomarkers in a patient's genetic material. It encompasses various technologies and tests, such as PCR, DNA sequencing, and microarrays, to aid in disease detection, diagnosis, and personalized treatment.

Key Players

MRFR recognizes the following companies as the key players in the global Molecular Diagnostics market— Agilent Technologies, Thermo Fisher Scientific, Becton Dickinson and Company, Abbott Laboratories, and Hoffman La Roche Ltd.

Segment Analysis

The global Molecular Diagnostics market has been segmented based on Products, Technique, Application and End-User.

On the basis of Products, the market is segmented into reagents & kits, instruments, and services & software. With 9.1 billion dollars in revenue, the reagents & kits category dominated the market with 49.2% of the total.  It is projected that it will continue to maintain its dominance in the upcoming years due to its widespread application in research and therapeutic settings. Standard reagents facilitate timely and accurate findings.

Based on Technique, the global Molecular Diagnostics market has been segmented into polymerase chain reaction (PCR), isothermal amplification, hybridization, sequencing, microarray, and others. The segment's revenue share that was greatest in 2022 was the polymerase chain reaction (PCR) segment. This is explained by the fact that it is used to identify COVID-19 and other infectious disorders.

Based on Application, the global Molecular Diagnostics market has been segmented into infectious diseases, oncology, genetic tests, and others. The molecular diagnostics market's largest revenue share belonged to the infectious illness sector. The increased use of molecular diagnostics, particularly PCR tests, for the diagnosis of COVID-19, is the main driver of this market's dominance.

Based on End-User, the global Molecular Diagnostics market has been segmented into hospitals & clinics, diagnostic laboratories, and others. The hospital and clinic sector is anticipated to dominate the molecular diagnostics market. A number of factors, including the ageing population growth and the high prevalence of healthcare-associated illnesses (HAIs), affect this demographic segment's share of hospital admissions.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Molecular Diagnostics Market Research Report

Regional Analysis

The global Molecular Diagnostics market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Molecular Diagnostics market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Molecular Diagnostics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Molecular Diagnostics market comprises of Middle East, Africa, and Latin America.

The North American Molecular Diagnostics Market dominated this market in 2022. The development of the healthcare system in the United States and an increase in the prevalence of infectious diseases and cancer have prompted a move away from conventional diagnostic techniques and towards molecular diagnostics.

Additionally, the second-largest market share for Molecular Diagnostics is held by Asia-Pacific. due to the high level of unmet needs in the sector and growing market penetration. The Asia Pacific market is anticipated to grow as a result of the region's steadily growing patient population, early identification, tailored therapy, and early prevention. Molecular diagnostics are now widely used in India, a huge increase from previous years.

Moreover, The Molecular Diagnostics Market in Europe is anticipated to grow quickly between 2023 and 2032. This is associated with the rise in infectious and chronic illness prevalence, which has fueled R&D initiatives and accelerated market growth. High standards of living, consumer knowledge of early diagnosis, and an established healthcare system are important determinants of expansion. Additionally, the UK molecular diagnostics market was the fastest-growing market in the European region, with the German molecular diagnostics market having the biggest market share.

Key Findings of the Study

• The global Molecular Diagnostics market is expected to reach USD 30.46 billion by 2032, at a CAGR of 5.70% during the forecast period.


• The North American Molecular Diagnostics Market dominated this market in 2022. The development of the healthcare system in the United States and an increase in the prevalence of infectious diseases and cancer have prompted a move away from conventional diagnostic techniques and towards molecular diagnostics.


• Based on Products, the reagents & kits segment dominated the market, accounting for 49.2% of market revenue (9.1 billion).


• Agilent Technologies, Thermo Fisher Scientific, Becton Dickinson and Company, Abbott Laboratories, and Hoffman La Roche Ltd.